Comparing Sharps Technology (STSS) & Its Competitors

Sharps Technology (NASDAQ:STSS) is one of 234 public companies in the “Surgical & medical instruments” industry, but how does it contrast to its competitors? We will compare Sharps Technology to similar businesses based on the strength of its profitability, institutional ownership, analyst recommendations, dividends, earnings, valuation and risk.

Profitability

This table compares Sharps Technology and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sharps Technology	N/A	-102.25%	-72.97%
Sharps Technology Competitors	-673.57%	-130.38%	-27.83%

Insider and Institutional Ownership

17.2% of Sharps Technology shares are held by institutional investors. Comparatively, 48.2% of shares of all “Surgical & medical instruments” companies are held by institutional investors. 12.6% of Sharps Technology shares are held by insiders. Comparatively, 15.5% of shares of all “Surgical & medical instruments” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings for Sharps Technology and its competitors, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sharps Technology	0	0	0	0	N/A
Sharps Technology Competitors	1695	4493	8666	234	2.49

As a group, “Surgical & medical instruments” companies have a potential upside of 29.91%. Given Sharps Technology’s competitors higher possible upside, analysts plainly believe Sharps Technology has less favorable growth aspects than its competitors.

Earnings and Valuation

This table compares Sharps Technology and its competitors revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Sharps Technology	N/A	-$9.84 million	-0.46
Sharps Technology Competitors	$1.03 billion	$3.51 million	-4,293.33

Sharps Technology’s competitors have higher revenue and earnings than Sharps Technology. Sharps Technology is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Volatility and Risk

Sharps Technology has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500. Comparatively, Sharps Technology’s competitors have a beta of 0.98, indicating that their average stock price is 2% less volatile than the S&P 500.

Summary

Sharps Technology competitors beat Sharps Technology on 6 of the 9 factors compared.

Sharps Technology Company Profile

Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.